where R is residue of uracil, thymine, cytosine or purine; R'' is hydrogen atom, acyl, alkyl, monophosphate, diphosphate or triphosphate or its pharmaceutically acceptable salts that show anti-HBV or anti- EBV activity. Invention describes also method of inhibition of HBV or EBV infection. EFFECT: new compounds indicated above, valuable antiviral properties. 13 cl, 20 dwg, 2 tbl, 5 ex"/>
L-NUCLEOSIDES ELICITING ANTI-HBV OR ANTI-EBV ACTIVITY, METHOD OF INHIBITION OF HBV OR EBV INFECTION
首页>
外国专利>
L-NUCLEOSIDES ELICITING ANTI-HBV OR ANTI-EBV ACTIVITY, METHOD OF INHIBITION OF HBV OR EBV INFECTION
L-NUCLEOSIDES ELICITING ANTI-HBV OR ANTI-EBV ACTIVITY, METHOD OF INHIBITION OF HBV OR EBV INFECTION
展开▼
机译：提倡抗-HBV或抗-EBV活性的L-核苷，抑制HBV或EBV感染的方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
FIELD: organic chemistry, biochemistry, virology. SUBSTANCE: invention describes novel L-nucleosides of the general formula (I) where R is residue of uracil, thymine, cytosine or purine; R'' is hydrogen atom, acyl, alkyl, monophosphate, diphosphate or triphosphate or its pharmaceutically acceptable salts that show anti-HBV or anti- EBV activity. Invention describes also method of inhibition of HBV or EBV infection. EFFECT: new compounds indicated above, valuable antiviral properties. 13 cl, 20 dwg, 2 tbl, 5 ex
展开▼
机译：领域：有机化学，生物化学，病毒学。物质：本发明描述了通式（I）的新型L-核苷。<图像文件=“ 00000002.GIF” he =“ 37” id =“ imag00000002” imgContent =“ undefined” imgFormat =“ GIF” wi =“ 33” / >其中R是尿嘧啶，胸腺嘧啶，胞嘧啶或嘌呤的残基; R”是氢原子，酰基，烷基，一磷酸，二磷酸或三磷酸或其显示出抗HBV或抗EBV活性的药学上可接受的盐。本发明还描述了抑制HBV或EBV感染的方法。效果：以上指出的新化合物，有价值的抗病毒特性。 13厘升，20载重吨，2汤匙，5前
展开▼
